首页> 外国专利> Systems for transdermal administration of beta-lactam antibiotics

Systems for transdermal administration of beta-lactam antibiotics

机译:β-内酰胺类抗生素的透皮给药系统

摘要

A compound of structure 1 ** Formula ** in which X is selected from O, S, CH2, and NH; Y is selected from H, OH, NHCHO, OCOCH3, OCH3, OC2H5, CH3SO3, NO2, CN, CF3, OCF3, F, Br, I, and Cl; ** Formula ** in which Z is S; -X1 is selected from -H, -OH, -OCH3, -OC2H5, OC3H7, -CONH2, -CH2OCONH2, -CH2OCOCH3, -OCOCH3, - CH2OCOCH3, -CH2OCH3, -CH3, -C2H5, -C3H7, -C4H9, C5H11 , C6H13, -Cl, -F, -Br, -I, -HC = CHCH3, -HC = CH2, -CH2OCH3, ** Formula ** in which R5 is selected from H, CONH2, CH2CH2N (CH3) 2, CH2CH2N (CH2CH3) 2, Cl, F, Br, I, alkyl residues having 1 to 12 carbon atoms, alkyloxy residues having 1 to 12 carbon atoms, alkenyl residues having up to 12 carbon atoms, and alkynyl residues having up to 12 carbon atoms; Rs- is selected from: ** Formula ** R61OOCCH (NHR71) (CH2) nCONH-, R61OOCCH (NHR7) (CH2) nSCONH-, CF3SCH2CONH-, CF3CH2CONH-, CHF2SCH2CONH-, CH2FSCH2CONCH-, NH2COCH-, NH2COCH-2, NH2COCH-, NH2COCH-2, NH2COCH-, NH2COCH-, NH2COCH-, NH2COCH-, NH2CHCH-2, CH2COCH-, NH2CHCH-2, CH2COCH-, NH2CHCH-2, CH2COCH-, NH2CHCH-2, CH2COCH-, NH2COCH-, NH2COCH-, NH2COCH-, NH2CHCH-2, CH2COCH-, NH2CHCH-2, CH2COCH- (NH2COCH-) , CH2SCH2CONH-, CNCH2SCH2CONH-, CH3 (CH2) nCONH-, R71N = C (NR71) CH2CH2S-, R71N = C (NHR71) NHCO-, CH3C (Cl) = CHCH2SCH2CONH-, (CH3) 2C (OR61) -, CNCH2CONH-, CNCH2CH2S-, R71N = C (NR71) CH2CH2S-, CH2 = CHCH2SCH2CONH-, CH3CH (OH) -, CH3CH (OR81) -, CH3CH (Y11) -, (CH3) 2CH-, CH3CH2- , and CH3 (CH2) nCH = CH (CH2) mCONH-, or Rs and Y taken together are R61OCH2C (R51) =, in which n and m each independently are selected from 0, 1, 2, 3, 4, 5, and 6; X31 is selected from H, N3, SO3W, F, Cl, Br, I, OH, OCH3, OC2H5, CH3, and C2H5; X41 is N or CH; X51 is selected from CH2, S, O, and NH; R51 is selected from H, -CONH2, CH2CH2N (CH3) 2, CH2CH2N (CH2CH3) 2, CH2CH2OR61, Cl, F, Br, I, alkyl residues having 1 to 12 carbon atoms, alkyloxy residues having 1 to 12 carbon atoms, alkenyl residues having up to 12 carbon atoms, alkynyl residues having up to 12 carbon atoms, aryl residues, and heteroaryl residues; R61 is selected from H, F, Cl, Br, I, 2-oxo-1-imidazolidinyl, alkyl residues having 1 to 12 carbon atoms, alkyloxy residues having 1 to 12 carbon atoms, alkenyl residues having up to 12 carbon atoms, alkynyl residues having up to 12 carbon atoms, aryl residues (phenyl, 5-indanyl, 2,3-dihydro-1H-inden-5-yl) and heteroaryl residues (4-hydroxy-1,5 -naphthyridin-3-yl); R71 is selected from H, F, Cl, Br, I, CH3NHCOCH2CH (NHR81) CO, R51N = C (NHR61) NHCO-, COCH3, COR61, PO (OR51) OR61, alkyl residues having 1 to 12 atoms of carbon, alkyloxy residues having 1 to 12 carbon atoms, alkenyl residues having 1 to 12 carbon atoms, alkynyl residues having 1 to 12 carbon atoms, aryl residues, and heteroaryl residues; R81 is selected from the group consisting of H, F, Cl, Br, I, CH3, C2H5, CF3, CH2CH2 F, CH2CH2Cl, CH2CH2Br, CH2CH2I, CH2CHF2, CH2CF3, CH2F, CH2Cl, CH2Br, CH2I, C3H7, C4H9, C5H9 , CONH2, and CH2OCONH2; Y11, Y21, Y31 and Y41 each independently are selected from H, OH, OW, OCOW, OCOCH3, CH3, C2H5, C3H7, C4H9, SO3R61, CH2COOR81, OCH3, OC2H5, CH3SO3, NO2, CN, CF3, OCF3, CH = CHCONHCH2COOW, CH2 (CH2) nNR51R61, CH2 (CH2) nOR61, CH (CONH2) NHR61, COOR51, F, Br, I, and Cl; -W is selected from alkyl residues having 1 to 12 carbon atoms, alkyloxy residues having 1 to 12 carbon atoms, alkenyl residues having up to 12 carbon atoms, alkynyl residues having up to 12 carbon atoms, residues aryl, heteroaryl residues ** Formula **
机译:结构1 **式**的化合物,其中X选自O,S,CH2和NH; Y选自H,OH,NHCHO,OCOCH 3,OCH 3,OC 2 H 5,CH 3 SO 3,NO 2,CN,CF 3,OCF 3,F,Br,I和Cl; **式**,其中Z为S; -X1选自-H,-OH,-OCH3,-OC2H5,OC3H7,-CONH2,-CH2OCONH2,-CH2OCOCH3,-OCOCH3,-CH2OCOCH3,-CH2OCH3,-CH3,-C2H5,-C3H7,-C4H9,C5H11 ,C6H13,-Cl,-F,-Br,-I,-HC> = CHCH3,-HC> = CH2,-CH2OCH3,**式**,其中R5选自H,CONH2,CH2CH2N(CH3)2 ,CH 2 CH 2 N(CH 2 CH 3)2,Cl,F,Br,I,具有1至12个碳原子的烷基残基,具有1至12个碳原子的烷氧基残基,具有至多12个碳原子的烯基残基和具有至多12个碳原子的炔基残基原子Rs-选自:**式** ** R61OOCCH(NHR71)(CH2)nCONH-,R61OOCCH(NHR7)(CH2)nSCONH-,CF3SCH2CONH-,CF3CH2CONH-,CHF2SCH2CONH-,CH2FSCH2CONCH-,NH2COCH-,NH2CO NH2COCH-,NH2COCH-2,NH2COCH-,NH2COCH-,NH2COCH-,NH2COCH-,NH2CHCH-2,CH2COCH-,NH2CHCH-2,CH2COCH-,NH2CHCH-2,CH2COCH-,NH2CHCH-2,CH2COCH-,NH2 NH2COCH-,NH2COCH-,NH2CHCH-2,CH2COCH-,NH2CHCH-2,CH2COCH-(NH2COCH-),CH2SCH2CONH-,CNCH2SCH2CONH-,CH3(CH2)nCONH-,R71N> = C(NR71)CH2CH2S-,R71N> C(NHR71)NHCO-,CH3C(Cl)> = CHCH2SCH2CONH-,(CH3)2C(OR61)-,CNCH2CONH-,CNCCH2CH2S-,R71N> = C(NR71)CH2CH2S-,CH2> = CHCH2SCH2CONH-,CH3CH(OH )-,CH3CH(OR81)-,CH3CH(Y11)-,(CH3)2CH-,CH3CH2-和CH3(CH2)nCH> = CH(CH2)mCONH-,或Rs和Y一起是R61OCH2C(R51) > =,其中n和m各自独立地选自0、1、2、3、4、5和6; X31选自H,N 3,SO 3 W,F,Cl,Br,I,OH,OCH 3,OC 2 H 5,CH 3和C 2 H 5; X41为N或CH; X51选自CH 2,S,O和NH; R 51选自H,-CONH2,CH2CH2N(CH3)2,CH2CH2N(CH2CH3)2,CH2CH2OR61,Cl,F,Br,I,具有1至12个碳原子的烷基残基,具有1至12个碳原子的烷氧基残基,烯基具有至多12个碳原子的残基,具有至多12个碳原子的炔基,芳基和杂芳基; R61选自H,F,Cl,Br,I,2-氧代-1-咪唑啉基,具有1至12个碳原子的烷基残基,具有1至12个碳原子的烷氧基残基,具有至多12个碳原子的烯基残基,炔基具有至多12个碳原子的残基,芳基(苯基,5-茚满基,2,3-二氢-1H-茚满-5-基)和杂芳基(4-羟基-1,5-萘啶-3-基); R71选自H,F,Cl,Br,I,CH3NHCOCH2CH(NHR81)CO,R51N> = C(NHR61)NHCO-,COCH3,COR61,PO(OR51)OR61,具有1至12个碳原子的烷基残基,具有1至12个碳原子的烷氧基残基,具有1至12个碳原子的烯基残基,具有1至12个碳原子的炔基残基,芳基和杂芳基。 R81选自由H,F,Cl,Br,I,CH3,C2H5,CF3,CH2CH2 F,CH2CH2Cl,CH2CH2Br,CH2CH2I,CH2CHF2,CH2CF3,CH2F,CH2Cl,CH2Br,CH2I,C3H7,C4H9,C5H9组成的组,CONH2和CH2OCONH2; Y11,Y21,Y31和Y41各自独立地选自H,OH,OW,OCOW,OCOCH3,CH3,C2H5,C3H7,C4H9,SO3R61,CH2COOR81,OCH3,OC2H5,CH3SO3,NO2,CN,CF3,OCF3,CH> = CHCONHCH 2 COOW,CH 2(CH 2)nNR51R61,CH 2(CH 2)nOR61,CH(CONH 2)NHR61,COOR51,F,Br,I和Cl; -W选自具有1至12个碳原子的烷基残基,具有1至12个碳原子的烷氧基残基,具有至多12个碳原子的烯基残基,具有至多12个碳原子的炔基残基,芳基,杂芳基残基** *

著录项

  • 公开/公告号ES2633020T3

    专利类型

  • 公开/公告日2017-09-18

    原文格式PDF

  • 申请/专利权人 YU CHONGXI-TECHFIELDS BIOCHEM;

    申请/专利号ES20130161970T

  • 发明设计人 YU CHONGXI;

    申请日2006-12-10

  • 分类号C07D499;A61K31/43;A61K31/545;A61P31/04;

  • 国家 ES

  • 入库时间 2022-08-21 13:35:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号